AFFIMED N V's ticker is AFMD and the CUSIP is N01045108. A total of 147 filers reported holding AFFIMED N V in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,078,000 | -53.2% | 1,979,828 | -37.0% | 1.83% | -54.8% |
| Q2 2022 | $8,708,000 | +21.3% | 3,143,773 | +170.7% | 4.05% | +24.1% |
| Q3 2021 | $7,178,000 | -0.7% | 1,161,466 | +36.6% | 3.27% | -13.6% |
| Q2 2021 | $7,225,000 | -11.3% | 850,000 | -17.5% | 3.78% | -14.2% |
| Q1 2021 | $8,147,000 | +538.0% | 1,030,004 | +369.6% | 4.40% | +350.0% |
| Q4 2020 | $1,277,000 | +5.4% | 219,340 | -38.7% | 0.98% | -22.4% |
| Q3 2020 | $1,212,000 | -74.4% | 357,666 | -88.1% | 1.26% | -74.8% |
| Q1 2020 | $4,740,000 | -56.9% | 3,000,000 | -25.2% | 5.01% | -34.5% |
| Q4 2019 | $10,988,000 | +4656.7% | 4,010,155 | +5008.5% | 7.66% | +3319.2% |
| Q3 2019 | $231,000 | -88.8% | 78,500 | -89.0% | 0.22% | -84.2% |
| Q2 2019 | $2,054,000 | -3.3% | 715,754 | +41.5% | 1.41% | +15.7% |
| Q1 2019 | $2,124,000 | -4.4% | 505,736 | -29.2% | 1.22% | -37.4% |
| Q4 2018 | $2,221,000 | – | 714,079 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Public Equity Management, LLC | 3,209,013 | $6,578,000 | 0.40% |
| Telemetry Investments, L.L.C. | 367,067 | $752,000 | 0.35% |
| NEA Management Company, LLC | 3,888,888 | $7,972,000 | 0.29% |
| DAFNA Capital Management LLC | 92,500 | $190,000 | 0.14% |
| Tekla Capital Management LLC | 1,405,324 | $2,881,000 | 0.11% |
| Perceptive Advisors | 668,214 | $1,369,000 | 0.07% |
| MUHLENKAMP & CO INC | 72,786 | $149,000 | 0.05% |
| Orbimed Advisors | 1,799,700 | $3,689,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $513,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $820,000 | 0.01% |